Literature DB >> 34396488

Overexpression of pEGF improved the gut protective function of Clostridium butyricum partly through STAT3 signal pathway.

Miaopeng Ma1, Zitong Zhao1, Qianyi Liang1, Haokun Shen1, Zengjue Zhao1, Zhiyang Chen1, Rongxiao He1, Saixiang Feng1, Ding Cao1, Guanhua Gan1, Hejia Ye1, Weihong Qiu1, Jinbo Deng1, Feiping Ming1, Junhao Jia1, Chongjun Sun1, Jiayi Li1, Linghua Zhang2.   

Abstract

Clostridium butyricum (C. butyricum) is a probiotic that could promote animal growth and protect gut health. So far, current studies mainly keep up with the basic biological functions of C. butyricum, missing the effective strategy to further improve its protective efficiency. A recent report about C. butyricum alleviating intestinal injury through epidermal growth factor receptor (EGFR) inspired us to bridge this gap by porcine epidermal growth factor (EGF) overexpression. Lacking a secretory overexpression system, we constructed the recombinant strains overexpressing pEGF in C. butyricum for the first time and obtained 4 recombinant strains for highly efficient secretion of pEGF (BC/pPD1, BC/pSPP, BC/pGHF, and BC/pDBD). Compared to the wild-type strain, we confirmed that the expression level ranges of the intestinal development-related genes (Claudin-1, GLUT-2, SUC, GLP2R, and EGFR) and anti-inflammation-related gene (IL-10) in IPECs were upregulated under recombinant strain stimulation, and the growth of Staphylococcus aureus and Salmonella typhimurium was significantly inhibited as well. Furthermore, a particular inhibitor (stattic) was used to block STAT3 tyrosine phosphorylation, resulting in the downregulation on antibacterial effect of recombinant strains. This study demonstrated that the secretory overexpression of pEGF in C. butyricum could upregulate the expression level of EGFR, consequently improving the intestinal protective functions of C. butyricum partly following STAT3 signal activation in IPECs and making it a positive loop. These findings on the overexpression strains pointed out a new direction for further development and utilization of C. butyricum. KEY POINTS: • By 12 signal peptide screening in silico, 4 pEGF overexpression strains of C. butyricum/pMTL82151-pEGF for highly efficient secretion of pEGF were generated for the first time. • The secretory overexpression of pEGF promoted the intestinal development, antimicrobial action, and anti-inflammatory function of C. butyricum. • The overexpressed pEGF upregulated the expression level of EGFR and further magnified the gut protective function of recombinant strains which in turn partly depended on STAT3 signal pathway in IPECs.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Antibacterial activity; Clostridium butyricum; Epidermal growth factor receptor; IL-6/IL-10; STAT3

Mesh:

Substances:

Year:  2021        PMID: 34396488     DOI: 10.1007/s00253-021-11472-y

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  65 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  EGFR antagonists in cancer treatment.

Authors:  Fortunato Ciardiello; Giampaolo Tortora
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

3.  Acetaldehyde disrupts tight junctions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine.

Authors:  S Basuroy; P Sheth; C M Mansbach; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-02-17       Impact factor: 4.052

4.  Oral administration of a product derived from Clostridium butyricum in rats.

Authors:  Yoshio Araki; Akira Andoh; Yoshihide Fujiyama; Jyou Takizawa; Wataru Takizawa; Tadao Bamba
Journal:  Int J Mol Med       Date:  2002-01       Impact factor: 4.101

5.  Positive effects of a Clostridium butyricum-based compound probiotic on growth performance, immune responses, intestinal morphology, hypothalamic neurotransmitters, and colonic microbiota in weaned piglets.

Authors:  Guangtian Cao; Fei Tao; Yuhua Hu; Zhanming Li; Yan Zhang; Bo Deng; Xiu'an Zhan
Journal:  Food Funct       Date:  2019-05-22       Impact factor: 5.396

Review 6.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

7.  Epidermal growth factor improved alcohol-induced inflammation in rats.

Authors:  Ya-Ling Chen; Hsiang-Chi Peng; Yi-Ching Hsieh; Suh-Ching Yang
Journal:  Alcohol       Date:  2014-08-08       Impact factor: 2.405

8.  Combinatorial Sec pathway analysis for improved heterologous protein secretion in Bacillus subtilis: identification of bottlenecks by systematic gene overexpression.

Authors:  Jingqi Chen; Gang Fu; Yuanming Gai; Ping Zheng; Dawei Zhang; Jianping Wen
Journal:  Microb Cell Fact       Date:  2015-06-26       Impact factor: 5.328

9.  Co-expressing GroEL-GroES, Ssa1-Sis1 and Bip-PDI chaperones for enhanced intracellular production and partial-wall breaking improved stability of porcine growth hormone.

Authors:  Jinbo Deng; Jiaoqing Li; Miaopeng Ma; Peijing Zhao; Feiping Ming; Zhipeng Lu; Juqing Shi; Qin Fan; Qianyi Liang; Junhao Jia; Jiayi Li; Shuxia Zhang; Linghua Zhang
Journal:  Microb Cell Fact       Date:  2020-02-18       Impact factor: 5.328

10.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer.

Authors:  Jennifer L Bishop; Daksh Thaper; Amina Zoubeidi
Journal:  Cancers (Basel)       Date:  2014-04-09       Impact factor: 6.639

View more
  2 in total

Review 1.  Effect of Clostridium butyricum on Gastrointestinal Infections.

Authors:  Tadashi Ariyoshi; Mao Hagihara; Motomichi Takahashi; Hiroshige Mikamo
Journal:  Biomedicines       Date:  2022-02-18

Review 2.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.